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Background. Mucins are the major components of mucus and their genes share a common, centrally-located region of
sequence that encodes tandem repeats. Mucins are well known genes with respect to their specific expression levels; however,
their genomic levels are unclear because of complex genomic properties. In this study, we identified eight novel minisatellites
from the entire MUC2 region and investigated how allelic variation in these minisatellites may affect susceptibility to
gastrointestinal cancer. Methodology/Principle Findings. We analyzed genomic DNA from the blood of normal healthy
individuals and multi-generational family groups. Six of the eight minisatellites exhibited polymorphism and were transmitted
meiotically in seven families, following Mendelian inheritance. Furthermore, a case-control study was performed that
compared genomic DNA from 457 cancer-free controls with DNA from individuals with gastric (455), colon (192) and rectal
(271) cancers. A statistically significant association was identified between rare exonic MUC2-MS6 alleles and the occurrence of
gastric cancer: odds ratio (OR), 2.56; 95% confidence interval (CI), 1.31–5.04; and p=0.0047. We focused on an association
between rare alleles and gastric cancer. Rare alleles were divided into short (40, 43 and 44) and long (47, 50 and 54), according
to their TR (tandem repeats) lengths. Interestingly, short rare alleles were associated with gastric cancer (OR=5.6, 95% CI:
1.93–16.42; p=0.00036). Moreover, hypervariable MUC2 minisatellites were analyzed in matched blood and cancer tissue from
28 patients with gastric cancer and in 4 cases of MUC2-MS2, minisatellites were found to have undergone rearrangement.
Conclusions/Significance. Our observations suggest that the short rare MUC2-MS6 alleles could function as identifiers for
risk of gastric cancer. Additionally, we suggest that minisatellite instability might be associated with MUC2 function in cancer
cells.
Citation: Jeong YH, Kim MC, Ahn E-K, Seol S-Y, Do E-J, et al (2007) Rare Exonic Minisatellite Alleles in MUC2 Influence Susceptibility to Gastric
Carcinoma. PLoS ONE 2(11): e1163. doi:10.1371/journal.pone.0001163
INTRODUCTION
Mucins are high molecular weight epithelial glycoproteins that are
contained in mucus, a viscous secretion that covers epithelial
surfaces [1]. Mucin oligosaccharides are attached to the protein
backbone via O-glycosidic linkages to the hydroxyl groups of
serine and threonine. They play an important role in the
protection of epithelial cells and have been implicated in the
process of epithelial renewal and differentiation [2,3]. Twenty
human mucin genes have been identified and classified function-
ally. They comprise both secreted gel-forming mucins and
transmembrane mucins, although some MUC gene products do
not fit well into either class [1]. Four of these MUC genes (MUC6,
MUC2, MUC5AC and MUC5B) are believed to encode gel-forming
mucins and they are clustered between H-ras and IGF2 on
chromosome 11p15.5 [4].
Analysis of human MUC gene sequences has identified the
presence of several features that may represent important
functional domains in mucin glycoproteins [1]. In the central
region of each mucin, there are a variable number of tandem
repeats (VNTR) comprised of threonine-, serine- and proline-rich
repeat peptides [1]. These tandem repeat (TR) units are
characteristic of mucin glycoproteins and exhibit substantial
genetic variation with respect to TR number. Although its effect
on function remains unclear, the TR number of several genes (H-
ras, hTERT, mucins and insulin genes) has been associated with
susceptibility to certain human diseases [5–12]. Individuals with
small MUC1 genotypes (SS) are at increased odds (4.3; 1.8–10.5)
for gastric carcinoma development [7]. There are several lines of
evidence which indicate that VNTR polymorphisms affect gene
expression [13,14]. These include problems arising from high
levels of polymorphism and consequent heterozygosity, which
influence both the haplotypes present in a given cell, as well as
which haplotype is responsible for gene expression. Comparison of
normal and cancer tissue has revealed rearrangement of at least
two VNTRs in hTERT and has suggested that minisatellites might
be associated with activation of telomerase expression in cancer
cells [15].
Human minisatellites are highly variable TR sequences located
predominantly in subtelomeric regions of the chromosome
[16,17]. MUC2 is located in the subtelomeric region of
chromosome 11 and its cDNA is 15,563 bp in length [18]. The
TR domain (MUC2-MS7 region in this study) is polymorphic due
to allelic variations in the length of MUC2 mRNA [9,19]. In
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the number of TRs encoded does not vary [20]. However,
a polymorphic locus was identified in intron 36 of MUC5B [21].
Thus, substantial allelic differences in the length of mucins may
occur in both exonic and intronic regions, and these may have
functional consequences that lead to differences in disease
susceptibility.
MUC2 is the major gel forming mucin secreted by goblet cells of
the intestine and it is the main structural component of the mucus
gel [22]. Expression of MUC2 is reduced in colorectal adenocar-
cinoma, although expression is observed in mucinous carcinomas
[23]. Normal gastric mucosa show little or no expression of MUC2,
but gastric carcinoma mucosa exhibit a heterogeneous mucin
expression pattern. Mucin genes expressed in normal gastric
mucosa include MUC1, MUC5AC and MUC6 [24,25], whereas
MUC2 is expressed aberrantly in 30% of gastric carcinomas [25].
The first aim of this study was to determine the genomic
features of the MUC2 region. Characterization of its structure
indicated the presence of repeated regions within MUC2 and both
exonic and intronic minisatellite regions were identified. In
addition, we examined the multiallelic properties of these analyzed
minisatellites. Since specific alleles of polymorphic minisatellites
are often linked to elevated odds for disease [5–12], our second
aim was to identify links between certain specific alleles of MUC2
minisatellites and susceptibility for gastrointestinal cancer. We
compared the allelic distribution in DNA samples from cancer-free
controls and patients with gastrointestinal cancer. Furthermore,
we compared the number of VNTR repeats in DNA from
matched blood and cancer tissue obtained from 28 gastric cancer
patients. Here, we report that allelic variations in the minisatellites
of MUC2 are related to susceptibility to gastric cancer.
RESULTS
Analysis of minisatellite polymorphisms in MUC2
Analysis of the MUC2 genomic DNA sequence (1–37,982 bp)
obtained from the UCL homepage indicated the presence of 49
exons and 48 introns (Figure 1A) [26]. Furthermore, analysis with
the Tandem Repeats Finder program [27] identified 9 tandem
repeats (algorithm scores .300). The length of these repeats, their
locations and consensus sequences are presented in Figure 1B.
Given their presence in exons, two minisatellites (MUC2-MS6 and
-MS7) also contained repeated amino acids sequences (Figure 1B).
The degree of polymorphism within the minisatellites was
examined by PCR using diagnostic primers against human
genomic DNA samples isolated from cancer-free control individ-
uals.
We found seven intronic and two exonic MUC2 minisatellites
and their allelic size and frequencies are presented in Figure 1.
MUC2-MS1 was found in intron 2 and exhibited a polymorphic
pattern in cancer-free controls. The three alleles identified in MS1
ranged between 664 and 796 bp in length and contained 12–15
copies of the repeat unit (Table S1 and Figure 2A–a). In intron 6,
68 alleles of MUC2-MS2 were identified in DNA from 100 control
samples (number of alleles: N=200) using specific primers from
minisatellite-flanking sequences (Table S1 and Figure 2A–b). Most
individuals were heterozygous for MUC2-MS2 and the number of
repeats varied from 9 to 115 with 86 repeats present in the most
common allele (6% frequency). In intron 20, MUC2-MS3 was
found to be polymorphic and the number of repeats varied from
25.5 to 28, with the latter present in the most common allele (44%;
Table S1 and Figure 2A–c). In intron 23, MUC2-MS4 was found
to contain 4 alleles in which the number of repeats ranged between
1 and 10, with the most common allele (56%) containing 5 repeats
(Table S1 and Figure 2A–d). In intron 40, four alleles were
identified in MUC2-MS8 from 670 cases control samples (Table
S1 and Figure 2A–f). The number of repeats varied between 6 and
10, with the latter contained in the most common allele (57%). No
polymorphisms were observed in either MUC2-MS5 or MUC2-
MS9, which were found in introns 26 and 41, respectively.
Both exonic minisatellites (MUC2-MS6 and -MS7) were
identified in exon 30 (Figure 1B). MUC2-MS6 contained a 24
bp repeat unit (ACCACTCCCAGCCCTCCACCAACC), which
encoded an eight amino acid repeat that was threonine (T), serine
(S) and proline (P) rich (TTPSPPPT; Figure 1B). MUC2-MS7
contained a 69 bp repeat that encoded a 23 amino acid proline/
threonine-rich sequence (PTTTPITTTTTVTPTPTPTGTQT;
Figure 1B). The primers used for the MUC2-MS6 and -MS7
regions were designed against genomic sequence from the UCL
homepage. MUC2-MS6 could be detected by PCR (Figure 2A–e).
We found 5 alleles in 457 controls samples and the number of
repeats varied between 40 and 54, with 45 repeats present in the
most common allele (93.7%). MS7 (69 bp repeat unit in exon 30)
could not be identified by PCR due to its size (.7 kb). However, it
was detected in a previous study by Southern blot analysis [9].
In summary, eight novel minisatellites were identified in MUC2,
six of which were polymorphic and two of which were mono-
morphic. The high density of minisatellites in this gene may relate
to its location near the telomere [17].
Mendelian inheritance of polymorphic minisatellites
in MUC2
In order to perform a segregation analysis of minisatellites in
MUC2, we selected family groups with two and three generations
(4 and 3 families, respectively). Blood was collected from the
grandparents (GF and GM), parents (F and M) and children (1 to
3) of each family. In controls, six polymorphic minisatellites
exhibited heterozygosity that ranged between 0.125-0.977 (Table
S1). Figure 2B illustrates the hereditary segregation of six
minisatellites during three generations of a family. In seven
families, alleles of MS1, MS2, MS3, MS4, MS6 and MS8 could be
identified and their transmission traced from parent to child.
These results demonstrate that minisatellites in MUC2 are subject
to Mendelian inheritance (i.e., children carried 1 minisatellite
allele from each parent). New minisatellite alleles were not
observed during this analysis. Thus, the minisatellites in MUC2
are meiotically stable in seven families and could potentially be
used as markers to follow meiotic segregation of MUC2 alleles.
Genetic susceptibility to cancer
Since minisatellites are genetically variable, it seems possible that
they could play a role in activating MUC2 during tumorigenesis.
This possibility was tested by comparing the distribution and
frequency of the polymorphic MUC2 minisatellite alleles between
controls and cancer patients with gastric, colon and rectal cancers.
For further analysis, each MUC2 minisatellite allele was grouped
into two sets (common and rare alleles), according to their frequency
in the control population. The expected frequency for rare alleles
was considered #1% in this study. Table 1 summarizes the
frequency of rare and common alleles for the MUC2-MS6 among
cancer cases and controls. In patients with gastric cancer, the rates
of rare MUC2-MS6 alleles were 3.3%, compared to 1.3% in cancer-
free controls. Analysis of these data revealed a statistically significant
association between rare alleles and odds of cancer: MUC2-MS6 for
gastric cancer (OR, 2.56; 95% CI, 1.31–5.96; p=0.0047).
Furthermore, rare cancer-specific MUC2-MS6 alleles were found
in patients with gastric (3 alleles: 44, 47 and 50 copies; Figure 3A–a)
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focused on the association between rare alleles and gastric cancer.
Rare alleles could be divided into short (40, 43 and 44) and long (47,
50 and 54), according to their tandem repeat lengths. Interestingly,
short rare alleles were associated with a relative probability of 5.6
(CI: 1.93–16.42; p=0.00036) for gastric cancer (Table 2). Analysis
of the number of rare alleles found in individual cancer cases and
healthy controls revealed that having at least one rare allele (C/R or
R/R) in MUC2-MS6 (cases : controls=6.4%:2.6%) was associated
with a relative gastric cancer odds of 2.52 (CI: 1.27–5.01;
p=0.0063) (Table 3). Two rare alleles (R/R) were only detected
in one patient with gastric cancer.
Supplemental Table S2 summarizes the frequency of rare
MUC2-MS6 alleles according to age at diagnosis. In the control
group, we found that there was no difference in the frequencies of
short rare alleles between younger (,50 years) and older
individuals ($50 years) (Table S2-1). In comparison to older
patients ($50 years), younger individuals (,50 years) with gastric
cancer had an increased odds (OR=1.80, CI: 0.71–4.56) of
having short rare MUC2-MS6 alleles but this was not statistically
significant (Table S2-2). Specifically, a comparison of the normal
controls and the cancer cases showed the following differences in
the association ratios between gastric and short rare MUC2-MS6
alleles in younger- and older-patients: younger, 7.79 (CI: 0.94–
64.53; p=0.026) vs. older 5.15 (CI: 1.48–17.93; p=0.004) (Table
S2–3). The frequency of short rare alleles was higher in younger
cases (,50 years) than in older cases ($50 years). These results
suggest that rare MUC2-MS6 alleles may be genetically associated
with cancer. This is the first report in which minisatellites of the
complete MUC2 region have been characterized in detail, and our
observations suggest that MUC2 minisatellite loci may function as
indicators of cancer risk.
Figure 1. Minisatellites in MUC2.A .Structure of the genomic region around MUC2. It is predicted that 49 exons (black boxes) encode MUC2.
Approximate positions of minisatellites identified by the Tandem Repeats Finder Program [22], are indicated by asterisks and numbers (MS1, 2, 3, 4, 5,
6, 7, 8, 9). B. The sequences of nine minisatellite repeat units. Positions of indices (1–37,982 bp) were determined using genomic information from the
UCL site [21].
doi:10.1371/journal.pone.0001163.g001
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from the 2004 Nationwide Gastric Cancer Report in Korea [28]
and from between 2002 and 2005 at Dong-A University (Table
S3). We examined the association between short rare alleles and
cancer according to differentiation (for tubular adenocarcinoma),
Lauren’s classification, N stages and TNM stages (Table S3). We
analyzed the gastric tumors according to their classification, and
then estimated the frequency of each stage in the total gastric
cancer group and in the short rare allele group by Pearson’s chi-
squared test (Table S3). Tubular adenocarcinomas represented ca.
90% of the gastric carcinomas. The gastric cancers were divided
into the following differentiation groups: well (35.3%), moderate
(28.0%) and poor (36.7%). The frequencies of short rare alleles in
these classes were 15.7%, 21.1% and 63.2%, respectively. Thus,
the frequency of short rare allele cases in the ‘poor’ differentiation
group was significantly higher than in the total gastric adenoma
group (p,0.0004). These results indicate an increased frequency of
short rare alleles in ‘poor’ differentiated cases and a reduced
Figure 2. Polymorphic patterns of MUC2 minisatellites (MS1, 2, 3, 4, 6, and 8) and their Inheritance. A. Polymorphic patterns of MS1 (a), MS2 (b),
MS3 (c), MS4 (d), MS6 (e), and MS8 (f). Minisatellites were PCR-amplified from genomic DNA of control samples using diagnostic primers. Allele
frequency, size of PCR products and repeat number are indicated in Table S1. Haplotype patterns are numbered according to each minisatellite. Size
markers (M) are given in kb (1 kb size marker) or bp (100 bp size marker). B. Meiotic inheritance of MUC2 minisatellites in a three-generation family:
MS1 (a), MS2 (b), MS3 (c), MS4 (d), MS6 (e), and MS8 (f). PCR primers specific to MUC2 minisatellites were used to analyze minisatellite length in
genomic DNA from family members. The pedigree demonstrates the relationship between family groups used in this study: first generation (lanes 1
and 2, grandfather and grandmother, respectively); second generation (lanes 3 and 7, fathers; lanes 4 and 8, mothers); and third generation (lanes 5
and 6, children from parents 3 and 4; lane 9, child from parents 7 and 8). M corresponds to the size marker.
doi:10.1371/journal.pone.0001163.g002
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frequency of diffused-type gastric cancer (according to Lauren’s
classification) was higher in short rare allele group than in the total
cancer group (p,0.038). However, we found a similar proportion
of TNM stage and N stages between the short rare alleles group
and the 455 gastric cancer group.
Analysis of minisatellite instability in cancer tissues
MUC2 contains a high density of minisatellites that may play a role
in its chromosomal instability. This idea was examined by
comparing the polymorphic alleles of hypervariable MUC2-MS2
minisatellites (heterozygosity.90%) in the blood and cancer
tissues from 28 patients with gastric cancer. These cancer tissues
were not included in determination of rare alleles for each
minisatellite because of their small sample size. In DNA obtained
from both blood and cancer tissue of patients with gastric cancer,
there were four cases of small deletions or loss of heterozygosity
(LOH) in MUC2-MS2 in DNA obtained from cancer tissues
(Figure 3B). Among the 28 gastric cancer patients, the frequency of
rearrangement was 14.3% in MUC2-MS2.
DISCUSSION
Mucins are the major components of mucus, which covers the
delicate epithelial surfaces of the intestines, airways and re-
productive tracts. All MUC genes contain a centrally-located
region of sequence that encodes tandem repeats and most mucin
genes exhibit a high degree of genetically-determined poly-
morphism, due to variation in the number of tandem repeats in
the TR domain [1]. Sequence analysis of the entire MUC2 gene
allowed the identification of nine tandem repeats. Eight of these
Figure 3. MUC2 minisatellites in cancer tissues. A. Rare, cancer-specific alleles are identified in MUC2-MS6. Comparison of rare cancer-specific alleles
of MUC2-MS6 between control (Figure 2A-f) and patients with gastric (a), and colon cancer (b). In patients with gastric cancer, four rare cancer-specific
alleles were identified (a); and in patients with colon cancer, two rare cancer-specific alleles were identified (b). Haplotype patterns are numbered for
MUC2-MS6 in gastric (a) and colon cancer (b). Rare cancer-specific alleles are indicated by arrows in (a) and (b). Size markers (M) are given in kb. B.
Instability of MUC2 minisatellites in blood and cancer tissue from patients with gastric tumors. Genomic DNA was analyzed from the blood and gastric
cancer tissue of patients. The sizes of minisatellites were analyzed by PCR. Results are shown for MUC2-MS2. Gastric cancer tissue samples are
indicated by asterisks and M indicates the size marker. Rearrangements in cancer tissues are indicated by arrows.
doi:10.1371/journal.pone.0001163.g003
Table 1. Frequency of rare MUC2–MS6 alleles and risk of cancer.
..................................................................................................................................................
MS6
Analyzed
alleles Common alleles Rare alleles OR (95% CI) p x
2-value**
41 45 Total (%) 40 43 44 47 50 54 57 Total (%)
Control 914 46 856 902 (98.7) 1 3 8 12 (1.3) 1.00 (Reference)
Gastric cancer 910 52 828 880 (96.7) 1 17 4 2 3 3 30 (3.3) 2.56 (1.31–5.04) 0.0047* 7.12
GC-Group I 470 27 426 453 (96.4) 1 10 2 2 1 1 17 (3.6) 2.82 (1.34–5.96) 0.0046* 6.95
GC-Group II 440 25 402 427 (97.0) 7 2 2 2 13 (3.0) 2.29 (1.04–5.05) 0.036* 3.56
Colon cancer 384 9 366 375 (97.7) 2 2 1 2 2 9 (2.3) 1.93 (0.93–4.04) 0.07 1.22
Rectal cancer 542 27 508 535 (98.7) 4 2 1 7 (1.3) 1.17 (0.53–2.59) 0.71 0.04
GC-Group I and II represent two different groups with gastric cancer. They were obtained from two different hospital groups in two different cities (Dong-A University [I]
and Chungbuk University [II]).
*Statistically significant (p,0.05).
**Pearson’s Chi-squared test with simulated p-value (based on 10,000 replicates).
doi:10.1371/journal.pone.0001163.t001
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PLoS ONE | www.plosone.org 5 November 2007 | Issue 11 | e1163are novel minisatellites that can be detected by PCR. Following
analysis of the GenBank database using the programs BLASTN,
we found no significant similarity between the eight novel
minisatellites and such regions identified previously. Thus, all
the minisatellites examined in this study are unique to MUC2 and
the properties they confer may be related directly to MUC2
function.
Minisatellites are tandemly-repeated DNA sequences that are
dispersed throughout the genome and which are conserved in
humans and other mammals. However, the role that minisatellites
play remains unclear. A characteristic of these repetitive sequences
is their ability to give rise to variants that contain increased or
decreased numbers of repeats. Minisatellites in the 39-region
flanking H-ras bind the rel/NF-kB family of transcription factors,
which contribute to the transcriptional activation of H-ras [29]. It
is possible that polymorphism in a 46 bp VNTR of human
interleukin-1a [30] is also relevant to gene function, since this
repeat was described as containing three potential transcriptional
factor-binding sites. Similarly, the hTERT VNTR 2-2 contains
CACGT-binding sites for the MYC family of oncogenic transcrip-
tion factors [15] and this gene has at least six alternative splicing
sites, one of which (b site) produces mRNA lacking exons 7 and 8
that results in a protein that is catalytically-inactive and which has
a C-terminal truncation [31]. In MUC2-MS5 and -MS8 (introns
26 and 40, respectively) we also found several canonical CACGT-
binding sites for the MYC family of oncogenic transcription factors.
Furthermore, alternatively-spliced transcript variants of MUC2
that include variations in intron 30 and exon 30 have been
described previously [32]. Therefore, our data suggest that these
minisatellites may contain sequences that are involved in two
major regulatory mechanisms for MUC2: transcriptional control of
MUC2 and alternative splicing of MUC2 transcripts.
Rare alleles of VNTRs are associated high risk for various types
of cancer [5]. VNTR analysis of MUC1 found an association
between short alleles and gastric cancer [7]. It is now apparent that
mutations in repetitive sequences can cause human disease,
including several disorders that are associated with a dominant
mode of inheritance and cancer [33]. MUC2 has six polymorphic
(MS1, MS2, MS3, MS4, MS6 and MS8) minisatellites and their
segregation within families indicated that these minisatellites were
transmitted through meiosis, following Mendelian inheritance.
Therefore, these polymorphisms could be useful as markers for
meiotic segregation of MUC2 minisatellites during study of MUC2-
related inheritable diseases.
In this study, we examined allelic variation in MUC2 and
suggested that these variations may represent candidates for
susceptibility to gastrointestinal cancer. A case-control study was
performed using PCR-based methods to score MUC2 minisatellite
alleles in DNA from cancer-free controls and individuals with
gastric, colon and rectal cancers. Interestingly, the frequency of
short rare alleles was associated with a relative probability of 5.6
(CI: 1.93–16.42; p=0.00036) for gastric cancer. These data
suggest that the incidence of short rare MUC2-MS6 alleles is
significantly higher in gastric cancer patients than in cancer-free
controls when sex and age are taken into consideration. These
results suggest that rare MUC2-MS6 alleles may be genetically
Table 3. Frequency of at least one rare MUC2–MS6 allele in cancer cases and the risk of cancer.
..................................................................................................................................................
MS6 Total case (allele)*** C/C C/R+R/R OR (95% CI) p x
2-value**
Control (%) 457 (914) 445 (97.4%) 12 12 (2.6%) 1.00 (Reference)
Gastric cancer (%) 455 (910) 426 (93.6%) 28+1**** 29 (6.4%) 2.52 (1.27–5.01) 0.0063* 6.01
GC-Group I 235 (470) 219 (93.2%) 15+1**** 16 (6.8%) 2.71 (1.26–5.83) 0.0081* 5.39
GC-Group II 220 (440) 207 (94.0%) 13 13(5.9%) 2.33 (1.04–5.19) 0.034* 3.30
Colon cancer (%) 192 (384) 183 (95.3%) 9 9 (4.7%) 1.96 (0.93–4.13) 0.07 1.13
Rectal cancer (%) 271 (542) 264 (97.4%) 7 7 (2.6%) 1.17 (0.52–2.61) 0.70 0.04
GC-Group I and II represent two different groups with gastric cancer. They were obtained from two different hospital groups in two different cities (Dong-A University [I]
and Chungbuk University [II]).
*Statistically significant (p,0.05).
**Pearson’s Chi-squared test with simulated p-value (based on 10,000 replicates).
***One case had two alleles: C/C, two common alleles; C/R, one rare and one common allele; R/R, two rare alleles
[****One gastric cancer case had two rare alleles].
doi:10.1371/journal.pone.0001163.t003
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Table 2. Frequency of MUC2–MS6 alleles and risk of gastric cancer according to short/long tandem repeat length.
..................................................................................................................................................
MS6
Analyzed
alleles Common alleles Short rare alleles Long rare alleles
41 45 Total 40 43 44 Total 47 50 54 Total
Control 914 46 856 902 (98.7%) 1 3 0 4 (0.4%) 0 0 8 8 (0.9%)
Gastric cancer 910 52 828 880 (96.7%) 1 17 4 22 (2.4%) 2 3 3 8 (0.9%)
OR (95% CI) 1.0 (Reference) 5.6 (1.93–16.42) 1.03 (0.38–2.74)
p 0.00036* 0.96
x
2-value** 12.42 0.006
Samples were obtained from two different hospital groups in two different cities (Dong-A University [I] and Chungbuk University [II]).
*Statistically significant (p,0.05).
**Pearson’s Chi-squared test with simulated p-value (based on 10,000 replicates).
doi:10.1371/journal.pone.0001163.t002
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PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1163associated. This is the first report in which minisatellites have been
characterized in detail for the complete MUC2 gene and our
observations suggest that the loci of MUC2 minisatellites may
function as indicators of cancer risk in gastric cancers. In an
attempt to compare other cancer type and diseases of the
respiratory tract, we analyzed lung cancer and asthma (Leem et
al., unpublished results). Interestingly, the rare MUC2-MS6 alleles
may associate with relative high risk of lung cancer, but no with
a risk of asthma. However, the numbers of cases are insufficient at
the present time to make a significant statistical analysis (Leem et
al., unpublished results). As we mentioned above, MUC2-MS6 is
located within an exon. We speculate that the proposed
association between short rare MUC2-MS6 variants and gastric
cancer may reflect substantial genetic variation in the serine- and
threonine-rich TR units of mucin glycoproteins, which could lead
to the construction of inappropriate O-glycosylation structures.
We found a similar proportion TNM stage and N stage cancers
between the short rare alleles group and the 455 gastric cancer
group. This result suggests that there is no relationship between
the short rare allele and the appearance of metastasis in regional
lymph nodes. Hence, the frequencies of the short rare alleles
differed with respect to with respect to the differentiation of
tubular adenocarcinomas. Moreover, the frequency of these alleles
was higher in the diffused-type of gastric cancer (Lauren’s
classification) relative to the total cancer group. Poorly-differen-
tiated and diffused-type gastric cancer tissues are associated with
a poor prognosis [34]. These results may suggest that gastric
cancer cases with such rare alleles have a bad prognosis.
It has been suggested that genomic instability plays an
important role in cancer by accelerating the accumulation of
genetic changes that are responsible for cancer cell development
[35]. At the DNA level, genomic alterations include loss of
heterozygosity (LOH), mutation and microsatellite instability.
Microsatellites and minisatellites are divided by their length.
Minisatellites form clusters #20 kb in length, with repeat units
ranging between 10 and 100 bp; microsatellite clusters are shorter,
usually 50 to 200 bp long, and the repeat unit is usually 10 bp or
less [36]. MUC2 encodes a secreted gel-forming mucin and often,
its expression is reduced in colorectal adenocarcinoma, whereas
expression is unaltered in mucinous carcinomas, a distinct subtype
of colon cancer associated with microsatellite instability [37]. We
examined the MUC2-MS2 minisatellites in DNA from blood and
cancer tissue derived from 28 patients with gastric cancer, and
detected four cases with small deletions or loss of heterozygosity
(LOH) in MUC2-MS2 (Figure 3B); frequency of rearrangement
was 14.3%. This frequency is much higher than the minisatellite
regions of H-ras [38] and hTERT [15,39] that have been associated
previously with cancer tissues. Therefore, these results strongly
suggest that MUC2 contains a high density of minisatellites that
might be related to its chromosomal instability. This idea warrants
further investigation, such as a large scale epidemiological study
into the association of minisatellites and cancer risk. Such a study
should also provide a helpful reference for understanding the
function and complex genomic properties of mucins.
METHODS
Database searches, analyses and primer
construction for tandem repeat regions in MUC2
The MUC2 genomic DNA sequences (37,982 bp) were obtained
from the UCL website [21] and from NCBI (AC139749.4).
BLAST analysis (NCBI) between MUC2 mRNA (NM_002457, 1–
15,728 bp) and the two genomic sequences indicated major
sequence differences in the exon 30 region.
The Tandem Repeats Finder software package [26] was used to
analyze minisatellites and other repeated regions. Repeat units
between 10 and 100 bp in length that scored .300 in the program
algorithm were selected for further analysis. All primers used in
this work were designed using Primer3 software [40]. Primers were
made by the sequence on UCL site: MS1, F-CCCTT-
CCCCATCCCCAGCTA & R-GGCACTCACCCCAGCCTCTG;
MS2, F-GACCCCACGCTGGTGCTTTC & R-CCCCGAA-
GTGCACCGAGAAG; MS3, F-GGCCTTTCCTCAGCCC-
CAGA & R-GGCTGGTGCACCCACCTTGT; MS4, F-
TGTTCAGCATCTGCCACAGCAAG & R-TAGCATGCTC-
TACGGCACCCTCA; MS5, F- TGCATGGACACTGACACG-
CAAG & R-GCAGGGGCGAGGAGAGGAAG; MS6, F-
TGTTGCTGGCCCATGGATAAGTGT & R-AGGGGTT-
GTCGTTGAGAATGGTGA; MS7, F-CATCACCACCAC-
CACTACGGTGAC & R-CGGAGGATTGGATGTGGT-
CAACTC; MS8, F-GTAGGCCCCACCGTGTTT & R-
AGAAGCTCTGACATGACATCTTGGCC; MS9, F- CCTCT-
GCTGTGCCCCTTGAGAG & R-ACCTTCCAGGCAC-
CATCTTGCTC.
Preparation of genomic DNA from peripheral blood
lymphocytes and cancer tissues
The controls and cancer cases had a similar proportion of
individuals for sex and age (Table 4). The TNM stages and
histopathological characteristics were analyzed according to World
Health Organization (WHO) and Lauren classification systems
(Table 5). To assess the degree of minisatellite polymorphism in
MUC2, we analyzed unrelated healthy individuals (Table 1,
Table 2 and Table 3). In addition, we performed a case-control
study in which we compared the DNA from 457 cancer-free
controls with those obtained from individuals with gastric (455),
colon (192) and rectal (271) cancers (Table 4 and Table 5). In
addition, samples were obtained from seven multi-generational
family groups. We have validated our results using two different
groups with gastric cancer. All samples were obtained from two
different hospitals in two different cities (Dong-A University
Hospital [#IRB-06-10-02 & IRB-07-10-7; Busan, Korea] and the
Chungbuk National University Hospital [#IRB-2006-1;
Cheongju, Korea]). For PCR experiments, genomic DNA was
isolated from the peripheral leukocytes, which was taken from
400 mL of whole blood using a Blood and Cell Culture DNA Mini
Kit (Qiagen, CA).
A total of 28 cancerous tissues and their respective non-
cancerous tissues were obtained from patients with gastric cancer
and were immediately frozen in liquid nitrogen. Gastric cancer
and normal cells were laser capture microdissected using a Pix Cell
II LCM system and stained by the HistoGen LCM Frozen Section
Staining Kit (Arturus, USA). Malignant cells were captured and
their genomic DNA was isolated by using the PicoPure DNA
extraction kit (Arturus, USA).
Analysis of minisatellite polymorphism in MUC2
We analyzed MUC2 minisatellite polymorphisms by PCR, using
primers designed against the genomic sequence. PCR reactions
(40 mL) were performed in reaction mixes containing 100 ng
genomic DNA, 10 mM primers, 2.5 U Go Taq Flexi DNA
polymerase (Promega, WI), 50 mM KCl, 10 mM Tris-HCl (pH
9.0), 3.0 mM MgCl2, 0.2 mM dTTP, dCTP, dGTP and dATP.
PCR was performed in a 9700 Thermocycler (Perkin-Elmer, CT)
and the general thermocycling conditions were as follows: 2 min
initial denaturation at 94uC, followed by 30 cycles of 30 s at 94uC
and 1 min kb
21 at 68uC, then a final 7 min extension at 72uC.
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21)
using either SeaKem LE agarose (1%, MUC2-MS1, -MS2; 1.2%,
MUC2-MS5, -MS7; 2%, MUC2-MS4, -MS6, -MS8; Cambrex,
ME) or 3% MetaPhor agarose (MUC2-MS3; Cambrex) in 1xTAE
buffer.
Statistical Analyses
In general, the degree of polymorphism increases with the number
of alleles and ranges between 0 and 1. To evaluate the probability
of two randomly-chosen alleles being different (heterozygosity) at
a given locus, the following formula was used:
h~1{
X k
i~1
xi2
where xi
2 is the allele frequency of the ith allele at each
minisatellites locus [41].
Regression analyses were performed to determine the odds
ratios (ORs) for the association of gastric cancer and short rare
MUC2-MS6 alleles (or rare MUC2-MS6 alleles) between controls
and case groups. ORs were estimated using the natural logarithm
and its standard error. Where relevant, we used a chi-squared
test with one degree of freedom to assess statistical significance.
All tests were two-sided, with p,0.05 being considered
statistically significant. Statistical analyses were performed using
MS Excel with CHITEST and R statistical software (v2.5.1,
www.r-project.org) with chisq.test for the calculation of chi-
squared values.
SUPPORTING INFORMATION
Table S1 Comparison of allelic sizes and frequency of MUC2
minisatellites in controls. Eight novel minisatellites were identified
in MUC2 and six minisatellites (MS1, MS2, MS3, MS4, MS6 and
MS8) of which were polymorphic. The degree of polymorphism
Table 4. Age and sex distribution of cases and controls.
..................................................................................................................................................
Characteristic Level Controls, [N=457] N (%) GC Cases, [N=455] N (%) CC cases, [N=192] N (%) RC cases, [N=271] N (%)
Age (y) 30–49 100 (21.9) 96 (21.1) 35 (18.2) 52 (19.2)
50–59 150 (32.8) 121 (26.6) 44 (22.9) 72 (26.6)
60–69 111 (24.3) 152 (33.4) 64 (33.3) 94 (34.7)
70–79 87 (19.0) 78 (17.1) 40 (20.8) 48 (17.7)
80+ 9 (2.0) 8 (1.8) 9 (4.7) 5 (1.8)
Sex Women 148 (32.4) 158 (34.7) 75 (39.1) 104 (38.4)
Men 309 (67.6) 297 (65.3) 117 (60.9) 167 (61.6)
GC, Gastric cancer; CC, colon cancer; RC, rectal cancer
doi:10.1371/journal.pone.0001163.t004
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Table 5. Tumor characteristics in cases with cancer.
..................................................................................................................................................
GC cases CC cases RC cases
No. of cases No. of cases No. of cases
WHO Histological Classification Papillary 3 Papillary 1 0
Tubular adenocarcinoma 402 Tubular adenocarcinoma 178 253
Mucinous 10 Mucinous 5 5
Signetring 23 Signetring 0 1
Others 13 Others 4 0
Unknown 4 Unknown 4 12
total 455 total 192 271
TNM Stage 08 04 3
Ia 195 I 18 63
Ib 76 IIa 83 88
II 63 IIb 16 11
IIIa 59 IIIa 5 21
IIIb 18 IIIb 40 34
IV 29 IIIc 21 41
IV 1 2
unknown 7 unknown 4 8
total 455 total 192 271
GC, Gastric cancer; CC, colon cancer; RC, rectal cancer
doi:10.1371/journal.pone.0001163.t005
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shown in range 0 to 1.
Found at: doi:10.1371/journal.pone.0001163.s001 (0.09 MB
DOC)
Table S2 The frequency of short rare MUC2-MS6 alleles
according to age at diagnosis. Table S2-1: Frequency of short rare
alleles at MUC2-MS6 associated with age in control. Table S2-2:
Frequency of short rare alleles at MUC2-MS6 associated with age
in gastric cancer cases. Table S2-3: Frequency of short rare
MUC2-MS6 alleles and risk of gastric cancer by age.
Found at: doi:10.1371/journal.pone.0001163.s002 (0.05 MB
DOC)
Table S3 Tumor characteristics in cases with gastric cancer.
Analysis of the association between short rare alleles and cancer
according to differentiation (for tubular adenocarcinoma), Lau-
ren’s classification, N stages and TNM stages. N stage is the N
classification of the TNM system and is classified by the
appearance of regional lymph nodes: N0; no regional lymph
nodes and N1,N3; metastasis in 1 or more regional lymph nodes.
We analyzed the gastric tumors according to their classification,
and then estimated the frequency of each stage in the total gastric
cancer group and in the short rare allele group by Pearson’s chi-
squared test.
Found at: doi:10.1371/journal.pone.0001163.s003 (0.05 MB
DOC)
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